Avidity Biosciences, Inc.
SEC CIK 1599901 · RNAM · last insider filing 2026-02-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Levin Arthur A | Director · Chief Scientific Officer | filed 2020 - 2026 |
| Boess Carsten | Director | filed 2020 - 2026 |
| Kaye Edward M. MD | Director | filed 2020 - 2026 |
| Wilson Troy Edward | Director | filed 2020 - 2026 |
| Boyce Sarah | Director · President and CEO | filed 2020 - 2026 |
| Mosbrooker Eric | Director · Chief Commercial Officer | filed 2021 - 2026 |
| Henig Noreen | Director | filed 2020 - 2026 |
| Thompson Tamar | Director | filed 2021 - 2026 |
| Kim Jean Jinsun | Director | filed 2021 - 2026 |
| Skerjanec Simona | Director | filed 2024 - 2026 |
| Wong Roderick | Director · MP and CIO | filed 2020 - 2021 |
| Chen Bihua | Director | filed 2020 - 2020 |
| Brady Todd C | Director | filed 2020 - 2020 |
| Martin Michael B. | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Maclean Michael F | Chief Financial Officer | filed 2020 - 2026 |
| Moriarty John B | Chief Legal Officer | filed 2024 - 2026 |
| Hughes Steven George | Chief Medical Officer | filed 2025 - 2026 |
| Flanagan W. Michael | Chief Technical Officer | filed 2021 - 2026 |
| Mccarthy Teresa | Chief Human Resources Officer | filed 2021 - 2026 |
| Gallagher Kathleen P. | Chief Program Officer | filed 2025 - 2026 |
| Calderaro Charles III | Chief Technical Officer | filed 2025 - 2026 |
| Baroldi Joseph | Chief Operating Officer | filed 2020 - 2021 |
| Kim Jae B. | Chief Medical Officer | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.